Bill > SRes285

This resolution designates July 16, 2025, as "Glioblastoma Awareness Day" while highlighting the critical nature of this aggressive brain cancer. The resolution provides context about glioblastoma, noting that approximately 13,000 Americans will be diagnosed in 2025, with over 10,000 expected to die from the disease, and emphasizing its extremely low 5-year survival rate of just 6.9%. The resolution aims to increase public awareness about the urgent medical needs of glioblastoma patients, honor those affected by the disease, and support research efforts. It specifically encourages collaboration among governmental, private, and nonprofit organizations to advance understanding and treatment, recognizes the importance of molecular biomarker testing, and supports continued investment in research through networks like the Glioblastoma Therapeutics Network. Additionally, the resolution highlights the challenging nature of the disease, describing it as affecting the "essence of self" due to its impact on the brain, and notes that despite being first described in the 1920s, only five drugs and one medical device have been approved to treat it, with mortality rates remaining largely unchanged over the past three decades.

https://www.congress.gov/bill/119th-congress/senate-resolution/285/all-info